Ending the HIV Epidemic

Administrative Supplements to Support Planning Activities at Existing NIH HIV/AIDS Centers to Address the “Ending the HIV Epidemic: A Plan for America” Initiative

We would like to announce an additional FY2020 supplement specific to Ending the Epidemic:

Research Topics:

  • EHE Team-initiated Implementation Research -  $200,000 Direct Costs 
  • Reaching Cisgender Heterosexual Women with PrEP - $150,000 Direct Costs
  • Evaluating and Developing Data-Driven Messages and Communication Strategies for EHE  - $150,000 Direct Costs 

The key aspects of these funding opportunities are:

  • Applications must include local partners as described in the announcement
  • Projects must address one or more of the four key pillars: Diagnose, Treat, Prevent, and Respond
  • Supplement awards are for one year
  • Project directors are restricted to early career investigators who have never received an R-series, R01-equivalent or U-series research grants.  Established investigators in non-HIV fields who have never received an NIH research award for HIV/AIDS studies are also eligible. Established investigators can be the project leaders for the core equipment and inter-CFAR meeting topics.
  • The CFAR may not fund studies involving new drugs, treatments, or devices, or off-label use of a licensed drug (this includes healthy volunteer studies where drugs are administered).
  • The CFAR may not fund clinical research studies that include randomization to one or more intervention to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.
  • Studies involving human subjects may be subject to additional NIH review prior to initiating the study, which may cause delays. Similarly, for studies with any foreign component, additional NIH review and approval is required prior to the initiation of any study procedures. More information can be found here

Please see the Supplement Announcement for full details on the areas of interest. 

We are only allowed to submit a limited number of supplement applications, so please submit a one page Letter of Intent (LOI) to CFAR@jhmi.edu no later than April 8th, 2020. The LOI is used to choose the projects that we will be submitting, so please "sell" your study!
The LOI should include:

  • Application title
  • List of investigators
  • Scientific Area of Interest
  • Aim(s)/Objective(s)
  • Summary of rationale and approach


The CFAR Developmental Core and Executive Committee will select projects to be developed into a full proposal for submission to the NIH.

  • The deadline for applications to be received at NIAID is May 18, 2020.
  • The earliest anticipated start date is 7/01/19 but may be delayed due to administrative issues.

The CFAR Grant Development and Implementation Toolkit is available online. It is a great resource that is designed to assist in the completion of HIV related grant submissions and to support the implementation of awarded grants. Our Cores and Scientific Working Groups are also available to assist with your proposal.

Any questions about the awards or the application process can be directed to cfar@jhmi.edu.